These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6162434)

  • 21. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
    Cullen MR; Kominsky JR; Rossman MD; Cherniack MG; Rankin JA; Balmes JR; Kern JA; Daniele RP; Palmer L; Naegel GP
    Am Rev Respir Dis; 1987 Jan; 135(1):201-8. PubMed ID: 3492158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beryllium disease.
    Saltini C; Amicosante M
    Am J Med Sci; 2001 Jan; 321(1):89-98. PubMed ID: 11202485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung.
    Saltini C; Kirby M; Trapnell BC; Tamura N; Crystal RG
    J Exp Med; 1990 Apr; 171(4):1123-40. PubMed ID: 2139099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity.
    Fontenot AP; Kotzin BL
    Tissue Antigens; 2003 Dec; 62(6):449-58. PubMed ID: 14617028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric test for beryllium sensitivity.
    Milovanova TN; Popma SH; Cherian S; Moore JS; Rossman MD
    Cytometry B Clin Cytom; 2004 Jul; 60(1):23-30. PubMed ID: 15221866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beryllium stimulates release of T helper 1 cytokines interleukin-2 and interferon gamma from BAL cells in chronic beryllium disease.
    Tinkle S; Kittle L; Schwitters PW; Addison JR; Newman LS
    Chest; 1996 Mar; 109(3 Suppl):5S-6S. PubMed ID: 8598153
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP; Maier LA
    Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitogenic effect of beryllium sulfate on mouse B lymphocytes but not T lymphocytes in vitro.
    Newmann LS; Campbell PA
    Int Arch Allergy Appl Immunol; 1987; 84(3):223-7. PubMed ID: 3498695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung function, biological monitoring, and biological effect monitoring of gemstone cutters exposed to beryls.
    Wegner R; Heinrich-Ramm R; Nowak D; Olma K; Poschadel B; Szadkowski D
    Occup Environ Med; 2000 Feb; 57(2):133-9. PubMed ID: 10711282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental berylliosis. I. Effects of a single intradermal injection of beryllium nitrate into guinea pigs.
    LEVY BM; HIGGINS GM
    J Invest Dermatol; 1961 Sep; 37():175-82. PubMed ID: 13761591
    [No Abstract]   [Full Text] [Related]  

  • 32. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
    Fontenot AP; Kotzin BL; Comment CE; Newman LS
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
    Milovanova TN
    Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of occupational exposure to beryllium and its compounds].
    Gaweda E; Madej M
    Med Pr; 2000; 51(3):221-8. PubMed ID: 11002468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of antigenic structure of nucleoproteid fraction of lungs in experimental berylliosis and silicosis].
    Alekseeva OG; Volkova AP
    Vestn Akad Med Nauk SSSR; 1967; 22(2):92-7. PubMed ID: 5620911
    [No Abstract]   [Full Text] [Related]  

  • 38. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C
    Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered adrenal function as an inducer of latent chronic beryllium disease.
    Clary JJ; Hopper CR; Stokinger HE
    Toxicol Appl Pharmacol; 1972 Nov; 23(3):365-75. PubMed ID: 5085451
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.
    Fontenot AP; Keizer TS; McCleskey M; Mack DG; Meza-Romero R; Huan J; Edwards DM; Chou YK; Vandenbark AA; Scott B; Burrows GG
    J Immunol; 2006 Sep; 177(6):3874-83. PubMed ID: 16951350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.